Essentials of Medical Pharmacology, 9th Edition (Revised Reprint)

pharmacology learning for medical students across India and neighbouring countries for more than four decades. Revised in accordance with the NMC's Competency-Based Medical Education (CBME) Curriculum 2024, it carries a carefully balanced blend of core pharmacology, clinical application and current therapeutics across 14 Sections, with learning objectives opening every chapter.

This edition is markedly more clinical than its predecessors. Core concepts are tied to practice through 118 cases for case-based learning and clinical insight boxes, so students learn not only what a drug does but when, why and how it is used. Recommendations from WHO, ACC/AHA, ISH, NICE, SIGN and GINA, together with meta-analyses and landmark clinical trials, underpin the therapeutic guidance.

The presentation is built for understanding and recall: revised tables, flowcharts, line diagrams and boxes highlight essential facts, comparisons and therapeutic principles, with important abbreviations gathered into a single reference section. Dedicated AETCOM modules bring ethical, communication and professional dimensions into pharmacological learning through clinical case scenarios.

What's New in This Edition:

Fully aligned with the CBME Curriculum 2024: pharmacology presented against the revised NMC competencies, with learning objectives in each chapter and integrated pharmacology-related AETCOM modules.

118 cases for case-based learning: core concepts linked to clinical application through patient-based scenarios and clinical insight boxes that answer the 'why' behind a prescription.

Latest drugs and therapeutic advances: GLP-1 receptor agonists, SGLT-2 inhibitors, neprilysin inhibitors, orexin antagonists, PCSK9 inhibitors, CGRP antagonists and other newer drugs.

Updated treatment algorithms: for diabetes, hypertension, heart failure, tuberculosis, cardiac arrest, infertility, peripheral vascular disease and asthma among others.

Evidence-based pharmacotherapy: supported by WHO, ACC/AHA, ISH, NICE, SIGN and GINA recommendations, meta-analyses and landmark clinical trials.

Current National Health Programme guidelines: incorporated for tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis and viral hepatitis.

Expanded antimicrobial stewardship: updated to include the WHO AWaRe classification of antibiotics.

Dedicated Pharmacovigilance Programme of India coverage: drug safety monitoring and rational therapeutic practice.

Recent advances in therapeutics: biologics, monoclonal antibodies, newer vaccines, immunomodulators and gene and cell-based therapies, with new classifications and figures.

Strengthened updates on core competencies: prescription writing, essential medicines, management of poisoning and therapeutic drug monitoring.